메뉴 건너뛰기




Volumn 44, Issue 4, 2011, Pages 265-269

Use of intravenous levetiracetam for management of acute seizures in neonates

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM; FOSPHENYTOIN SODIUM; LORAZEPAM; MIDAZOLAM; OXCARBAZEPINE; PHENOBARBITAL; PYRIDOXINE;

EID: 79952549970     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2010.11.005     Document Type: Article
Times cited : (118)

References (18)
  • 1
    • 0034167020 scopus 로고    scopus 로고
    • Neonatal seizures
    • Hill A. Neonatal seizures. Pediatr Rev 2000;21:117-21.
    • (2000) Pediatr Rev , vol.21 , pp. 117-121
    • Hill, A.1
  • 3
  • 5
    • 49849105442 scopus 로고    scopus 로고
    • New antiepileptic drugs in pediatric epilepsy
    • Hwang H, Kim KJ. New antiepileptic drugs in pediatric epilepsy. Brain Dev 2008;30:549-55.
    • (2008) Brain Dev , vol.30 , pp. 549-555
    • Hwang, H.1    Kim, K.J.2
  • 9
    • 47049102489 scopus 로고    scopus 로고
    • Off-Label Use of Antiepileptic Drugs for the Treatment of Neonatal Seizures
    • DOI 10.1016/j.pediatrneurol.2008.04.008, PII S0887899408001914
    • Silverstein FS, Ferriero DM. Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol 2008;39:77-9. (Pubitemid 351970659)
    • (2008) Pediatric Neurology , vol.39 , Issue.2 , pp. 77-79
    • Silverstein, F.S.1    Ferriero, D.M.2
  • 10
    • 66749161081 scopus 로고    scopus 로고
    • Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures
    • Abend NS, Monk HM, Licht DJ, Dlugos DJ. Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures. Pediatr Crit Care Med 2009;10:505-10.
    • (2009) Pediatr Crit Care Med , vol.10 , pp. 505-510
    • Abend, N.S.1    Monk, H.M.2    Licht, D.J.3    Dlugos, D.J.4
  • 11
    • 66349133603 scopus 로고    scopus 로고
    • Role of intravenous levetiracetam in acute seizure management of children
    • Kirmani BF, Crisp ED, Kayani S, Rajab H. Role of intravenous levetiracetam in acute seizure management of children. Pediatr Neurol 2009;41:37-9.
    • (2009) Pediatr Neurol , vol.41 , pp. 37-39
    • Kirmani, B.F.1    Crisp, E.D.2    Kayani, S.3    Rajab, H.4
  • 12
    • 42449127132 scopus 로고    scopus 로고
    • Efficacy of levetiracetam in children with epilepsy younger than 2 years of age
    • DOI 10.1177/0883073807309781
    • Krief P, Kan L, Maytal J. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age. J Child Neurol 2008;23:582-4. (Pubitemid 351566875)
    • (2008) Journal of Child Neurology , vol.23 , Issue.5 , pp. 582-584
    • Krief, P.1    Kan, L.2    Maytal, J.3
  • 13
    • 53249090387 scopus 로고    scopus 로고
    • Tolerability and dosing experience of intravenous levetiracetam in children and infants
    • Michaelides C, Thibert RL, Shapiro MJ, et al. Tolerability and dosing experience of intravenous levetiracetam in children and infants. Epilepsy Res 2008;81:143-7.
    • (2008) Epilepsy Res , vol.81 , pp. 143-147
    • Michaelides, C.1    Thibert, R.L.2    Shapiro, M.J.3
  • 14
    • 65549121241 scopus 로고    scopus 로고
    • Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures
    • Levetiracetam NO1009 Study Group
    • Pina-Garza JE, Nordii DR Jr, Rating D, Yang H, Shiemann-Delgado J, Duncan B. Levetiracetam NO1009 Study Group. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia 2009;50:1141-9.
    • (2009) Epilepsia , vol.50 , pp. 1141-1149
    • Pina-Garza, J.E.1    Nordii Jr., D.R.2    Rating, D.3    Yang, H.4    Shiemann-Delgado, J.5    Duncan, B.6
  • 15
    • 41949136803 scopus 로고    scopus 로고
    • Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: Dosing recommendations
    • DOI 10.2165/00003088-200847050-00004
    • Toublanc N, Sargentini-Maier ML, Lacroix B, Jacqmin P, Stockis A. Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: Dosing recommendations. Clin Pharmacokinet 2008;47:333-41. (Pubitemid 351508119)
    • (2008) Clinical Pharmacokinetics , vol.47 , Issue.5 , pp. 333-341
    • Toublanc, N.1    Sargentini-Maier, M.L.2    Lacroix, B.3    Jacqmin, P.4    Stockis, A.5
  • 16
    • 68749115013 scopus 로고    scopus 로고
    • Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy
    • Cilio M, Bianchi R, Balestri M, et al. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy. Epilepsy Res 2009;86:66-71.
    • (2009) Epilepsy Res , vol.86 , pp. 66-71
    • Cilio, M.1    Bianchi, R.2    Balestri, M.3
  • 17
    • 58149154641 scopus 로고    scopus 로고
    • Levetiracetam in children with refractory status epilepticus
    • Gallentine WB, Hunnicutt AS, Husain AM. Levetiracetam in children with refractory status epilepticus. Epilepsy Behav 2009;14:215-8.
    • (2009) Epilepsy Behav , vol.14 , pp. 215-218
    • Gallentine, W.B.1    Hunnicutt, A.S.2    Husain, A.M.3
  • 18
    • 34249852186 scopus 로고    scopus 로고
    • Levetiracetam for the treatment of neonatal seizures
    • DOI 10.1177/0883073807299973
    • Shoemaker MT, Rotenberg JS. Levetiracetam for the treatment of neonatal seizures. J Child Neurol 2007;22:95-8. (Pubitemid 46860448)
    • (2007) Journal of Child Neurology , vol.22 , Issue.1 , pp. 95-98
    • Shoemaker, M.T.1    Rotenberg, J.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.